Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
about
A pharmacological profile of ribavirin and monitoring of its plasma concentration in chronic hepatitis C infectionAnti-hepatitis C virus drugs and kidneyDirect-acting antivirals for the treatment of chronic hepatitis C in patients with chronic kidney diseaseHepatitis C virus infection and dialysis: 2012 update.Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies.Hepatitis C virus infection and kidney transplantation in 2014: what's new?Safety and efficacy of dual direct-acting antiviral therapy (daclatasvir and asunaprevir) for chronic hepatitis C virus genotype 1 infection in patients on hemodialysis.Efficacy and safety of hepatitis C antiviral therapy in moderate and severe chronic kidney disease.Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial.Hepatitis C and renal transplantation in era of new antiviral agentsRibavirin at the Era of Novel Direct Antiviral Agents for the Treatment of Hepatitis C Virus Infection: Relevance of Pharmacological Monitoring
P2860
Q27023355-6C31E91C-0128-4BFF-A007-FEF3D1663ED5Q28070279-590E709B-2F20-4BDE-80A7-ACD47F1E6FC5Q28077263-E3386490-D504-4554-BA06-B70344B583A0Q33710828-85241C9F-B10F-49B6-B49E-A6931597B13EQ38231457-84D3D72A-F92F-4ED1-BDB3-61FFB97B213EQ38236820-BDB8F6A2-D9AA-4170-8755-08B802974678Q40793177-0BE6E64A-61C5-450E-81FD-E90E0C2AF9B6Q42206661-44C713B3-078A-4C3D-9048-B09702C7B1B3Q42223532-770AA009-2338-4D7E-AF23-2CA0FF00BDC5Q58792851-A860C506-BB84-473F-81EA-2BEFE8AF7247Q59049605-2B9A1BCA-EBA1-44A7-85A9-6DB3F0718EC9
P2860
Anti-viral therapy in haemodialysed HCV patients: efficacy, tolerance and treatment strategy.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Anti-viral therapy in haemodia ...... erance and treatment strategy.
@en
Anti-viral therapy in haemodia ...... erance and treatment strategy.
@nl
type
label
Anti-viral therapy in haemodia ...... erance and treatment strategy.
@en
Anti-viral therapy in haemodia ...... erance and treatment strategy.
@nl
prefLabel
Anti-viral therapy in haemodia ...... erance and treatment strategy.
@en
Anti-viral therapy in haemodia ...... erance and treatment strategy.
@nl
P2093
P2860
P50
P1476
Anti-viral therapy in haemodia ...... lerance and treatment strategy
@en
P2093
I Ollivier
P2860
P304
P356
10.1111/J.1365-2036.2011.04741.X
P407
P577
2011-06-20T00:00:00Z